DAILY-EQUITY-REPORT BY EPIC RESEARCH 25 MARCH 2013

HEADLINES -=6

 Indian Market

DAILY EQUITY NEWSLETTER 25

TH



Indian equity markets were down 0.13%



Nifty down by 7.40 pts and settle at 5651.35



Sensex down by 57.27 pts at 18735.60



Bank Nifty down by 34.30 pts at 11204.05

 Global Market 

European markets were down with FTSE down by 4.18 closed at 6384 ,CAC down by 19.69 closed at 3755 and DAX down by 24.10 closed at 7908.



Dow future was up 11.00 closed at 14358.00

MARCH 2013

 HEADLINES • To resume operations in Andhra, may recover Rs 300cr: SKS • Dish TV to increase pack prices, stock gains 3% • Hike in excise duty could hurt UV sales • Mallya to submit Kingfisher Airline's revival plan next week

WWW.EPICRESEARCH.CO

09752199966

 MARKET ANALYSIS:  Immense volatility was witnessed on the bourses in late trade as key benchmark indices once again slipped into the red soon after moving into positive zone from negative zone. The barometer index, the S&P BSE Sensex, was provisionally down 55.12 points or 0.29%, off 122.07 points from the day's high and up 68.55 points from the day's low. The market breadth was weak. The BSE Small-Cap index was off almost 1%. Index heavyweight Reliance Industries (RIL) edged lower in volatile trade.

Another index heavyweight and cigarette major ITC edged higher in choppy trade.  Realty stocks extended recent losses. IT stocks edged lower as Oracle Corp's third quarter revenue fell short of analysts' expectations.  The market edged higher in early trade on firm Asian stocks. Key benchmark indices reversed initial gains and hit their lowest level in almost 2-1/2 weeks in morning trade. Volatility ruled the roost as key benchmark indices regained positive zone in mid-morning trade. Key benchmark indices held firm in early afternoon trade. The Sensex extended gains to hit fresh intraday high in afternoon trade.

Volatility ruled the roost as key benchmark indices reversed direction and slipped into the red in midafternoon trade as European stocks dropped after the European Central Bank warned that it will cut off emergency funding for Cyprus's troubled banks if Cyprus doesn't seal a bailout deal by Monday, 25 March 2013. The market extended losses to hit fresh intraday low in late trade.A bout of initial volatility was witnessed as key benchmark alternately swung between positive and negative zone. The Sensex continued to move alternately between gains and losses in morning trade.

STOCKS TO WATCH

 FII’s and DII’s



IDBI

CATEGORY

DATE

BUY

SELL

NET



IDEA CELLULAR

FII

22-Mar-13

2931.55

2945.75

-14.2



ITC

DII

22-Mar-13

1053.27

1188.84

-135.57



ICICI BANK

SCRIPS IN BAN PERIOD

 NIFTY DAILY PIVOTS

 PUNJLLYOD

PIVOT

R4

R3

R2

R1

PP

S1

S2

S3

S4

 HDIL

NIFTY

5837

5777

5717

5684

5657

5624

5597

5537

5477

 IVRCLINFRA

WWW.EPICRESEARCH.CO

09752199966

.

 GAINERS AND LOOSERS

EXPERT OPINION NIFTY

DAILY NIFTY GAINERS SCRIPS

RATE

VOL.

PR.

NET

%

(000)

CLOSE

CHAN

CHANG

GE

E

IDFC

143.15

8275.53

136.55

6.60

4.83

Ambuja Cement

176.00

2484.49

168.90

7.10

4.20

Bank Of Baroda

676.65

Bajaj Auto

1820.65

486.27

1755.30

65.35

3.72

Jindal Steel

352.75

1699.22

341.70

11.05

3.23

983.37

651.40

25.25



Nifty looks Bearish



Strategy: Sell on rise



Support: 5600



Resistance: 5700 BANK NIFTY



Bank Nifty looks Bearish



Strategy: Sell on rise



Support: 11150



Resistance: 11260

3.88

460 

.0 PREVIOUS PERFORMANCE

DAILY NIFTY LOOSERS SCRIPS

DLF Ranbaxy Labs.

RATE

230.95 432.05

VOL.

PR.

NET

%

(000)

CLOSE

CHAN

CHAN

GE

GE

10728.23 686.15

239.45 440.75

-8.50 -8.70

B/S

RESULT

CASH

DLF

S

TARGET HIT

CASH

RELIANC E CAPITAL

S

TARGET HIT

FUTURE

IDBI

S

NOT EXECUTED

FUTURE

AMBUJA

S

NOT EXECUTED

-1.97

321.85

3812.42

327.85

-6.00

-1.83

SBI

2083.95

2089.47

2119.45

-35.50

-1.67

820.50

937.37

831.30

-10.80

-1.30

WWW.EPICRESEARCH.CO

SCRIP

-3.55

Tata Steel

Sun Pharma

TYPE

09752199966

MARKET CALLS CASH

6 SCRIPS

ACTION

LEVEL

1ST TARGET

2ND TARGET

STOP LOSS

IDEA CELLULAR

SELL

106.80

106.30

105.80

107.30

PVR

SELL

285.00

283.00

281.00

287.00

FUTURE SCRIPS

ACTION

LEVEL

ST

1

TARGET

ND

2

TARGET

STOP LOSS

.

IDFC

BUY

144.70

145.70

146.70

143.70

AURO PHARMA

SELL

139.10

138.10

137.10

140.10

Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.

All Rights Reserved. Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.